Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases

Cell

Volumn 148, Issue 5, 2012, Pages 896-907

  Ding, Zhihu ^b,c   Wu, Chang Jiun ^a,b   Jaskelioff, Mariela ^b,c   Ivanova, Elena ^b   Kost Alimova, Maria ^a,b   Protopopov, Alexei ^a,b   Chu, Gerald C ^b,c   Wang, Guocan ^a,b,c   Lu, Xin ^a,b,c   Labrot, Emma S ^b   Hu, Jian ^a,b,c   Wang, Wei ^a,b,c   Xiao, Yonghong ^b   Zhang, Hailei ^b   Zhang, Jianhua ^a,b   Zhang, Jingfang ^b   Gan, Boyi ^b,c   Perry, Samuel R ^b   Jiang, Shan ^a,b   Li, Liren ^a,b   Horner, James W ^a,b   Wang, Y Alan ^a,b   Chin, Lynda ^a,b,c   Depinho, Ronald A ^a,b,c   more..

^a UNIVERSITY OF TEXAS   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; SMAD4 PROTEIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSFORMING GROWTH FACTOR BETA;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; CANCER GROWTH; COPY NUMBER VARIATION; DNA DAMAGE; ENZYME DEFICIENCY; ENZYME REACTIVATION; GENETIC STABILITY; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TELOMERE; TUMOR CELL;

MURINAE;

EID: 84862776643     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2012.01.039     Document Type: Article

References (57)

1. C. Abate-Shen, M.M. Shen, and E. Gelmann Integrating differentiation and cancer: The Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis Differentiation 76 2008 717 727 (Pubitemid 352032747)
2. V.D. Acevedo, M. Ittmann, and D.M. Spencer Paths of FGFR-driven tumorigenesis Cell Cycle 8 2009 580 588
3. A.A. Aitchison, A. Veerakumarasivam, M. Vias, R. Kumar, F.C. Hamdy, D.E. Neal, and I.G. Mills Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer Prostate 68 2008 661 674 (Pubitemid 351614644)
4. S.E. Artandi, and R.A. DePinho Telomeres and telomerase in cancer Carcinogenesis 31 2010 9 18
5. S.E. Artandi, S. Chang, S.L. Lee, S. Alson, G.J. Gottlieb, L. Chin, and R.A. DePinho Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice Nature 406 2000 641 645 (Pubitemid 30641052)
6. R. Beroukhim, G. Getz, L. Nghiemphu, J. Barretina, T. Hsueh, D. Linhart, I. Vivanco, J.C. Lee, J.H. Huang, and S. Alexander Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma Proc. Natl. Acad. Sci. USA 104 2007 20007 20012
7. S. Chang, C.M. Khoo, M.L. Naylor, R.S. Maser, and R.A. DePinho Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression Genes Dev. 17 2003 88 100 (Pubitemid 36062511)
8. Y.M. Chang, H.J. Kung, and C.P. Evans Nonreceptor tyrosine kinases in prostate cancer Neoplasia 9 2007 90 100
9. Z. Chen, L.C. Trotman, D. Shaffer, H.K. Lin, Z.A. Dotan, M. Niki, J.A. Koutcher, H.I. Scher, T. Ludwig, and W. Gerald Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis Nature 436 2005 725 730 (Pubitemid 41117277)
10. K. Chin, C.O. de Solorzano, D. Knowles, A. Jones, W. Chou, E.G. Rodriguez, W.L. Kuo, B.M. Ljung, K. Chew, and K. Myambo In situ analyses of genome instability in breast cancer Nat. Genet. 36 2004 984 988 (Pubitemid 39167495)
11. L. Chin, S.E. Artandi, Q. Shen, A. Tam, S.L. Lee, G.J. Gottlieb, C.W. Greider, and R.A. DePinho p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis Cell 97 1999 527 538 (Pubitemid 29231175)
12. F. d'Adda di Fagagna, P.M. Reaper, L. Clay-Farrace, H. Fiegler, P. Carr, T. Von Zglinicki, G. Saretzki, N.P. Carter, and S.P. Jackson A DNA damage checkpoint response in telomere-initiated senescence Nature 426 2003 194 198 (Pubitemid 37442589)
13. R.A. DePinho The age of cancer Nature 408 2000 248 254
14. Z. Ding, C.J. Wu, G.C. Chu, Y. Xiao, D. Ho, J. Zhang, S.R. Perry, E.S. Labrot, X. Wu, and R. Lis SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression Nature 470 2011 269 273
15. M.R. Emmert-Buck, R.F. Bonner, P.D. Smith, R.F. Chuaqui, Z. Zhuang, S.R. Goldstein, R.A. Weiss, and L.A. Liotta Laser capture microdissection Science 274 1996 998 1001 (Pubitemid 26398425)
16. P.A. Farazi, J. Glickman, J. Horner, and R.A. Depinho Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression Cancer Res. 66 2006 4766 4773
17. G. Feldmann, R. Beaty, R.H. Hruban, and A. Maitra Molecular genetics of pancreatic intraepithelial neoplasia J. Hepatobiliary Pancreat. Surg. 14 2007 224 232 (Pubitemid 46863910)
18. S.A. Forbes, N. Bindal, S. Bamford, C. Cole, C.Y. Kok, D. Beare, M. Jia, R. Shepherd, K. Leung, and A. Menzies COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer Nucleic Acids Res. 39 Database issue 2011 D945 D950
19. E. González-Suárez, E. Samper, J.M. Flores, and M.A. Blasco Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis Nat. Genet. 26 2000 114 117
20. Y. Guo, G.N. Sklar, A. Borkowski, and N. Kyprianou Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade Clin. Cancer Res. 3 1997 2269 2274 (Pubitemid 28133145)
21. W.C. Hahn, C.M. Counter, A.S. Lundberg, R.L. Beijersbergen, M.W. Brooks, and R.A. Weinberg Creation of human tumour cells with defined genetic elements Nature 400 1999 464 468 (Pubitemid 29361801)
22. J. Holzbeierlein, P. Lal, E. LaTulippe, A. Smith, J. Satagopan, L. Zhang, C. Ryan, S. Smith, H. Scher, and P. Scardino Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance Am. J. Pathol. 164 2004 217 227 (Pubitemid 38364606)
23. G. Hu, R.A. Chong, Q. Yang, Y. Wei, M.A. Blanco, F. Li, M. Reiss, J.L. Au, B.G. Haffty, and Y. Kang MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer Cancer Cell 15 2009 9 20
24. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J. Clin. 60 2010 277 300
25. R.B. Jenkins, J. Qian, M.M. Lieber, and D.G. Bostwick Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization Cancer Res. 57 1997 524 531 (Pubitemid 27081674)
26. T.R. Johnson, L. Khandrika, B. Kumar, S. Venezia, S. Koul, R. Chandhoke, P. Maroni, R. Donohue, R.B. Meacham, and H.K. Koul Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancer Mol. Cancer Res. 6 2008 1639 1648
27. B.V. Kallakury, T.P. Brien, C.V. Lowry, P.J. Muraca, H.A. Fisher, R.P. Kaufman Jr., and J.S. Ross Telomerase activity in human benign prostate tissue and prostatic adenocarcinomas Diagn. Mol. Pathol. 6 1997 192 198 (Pubitemid 28047556)
28. N. Kikuno, H. Shiina, S. Urakami, K. Kawamoto, H. Hirata, Y. Tanaka, R.F. Place, D. Pookot, S. Majid, M. Igawa, and R. Dahiya Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity Oncogene 26 2007 7647 7655 (Pubitemid 350224215)
29. M. Kim, J.D. Gans, C. Nogueira, A. Wang, J.H. Paik, B. Feng, C. Brennan, W.C. Hahn, C. Cordon-Cardo, and S.N. Wagner Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene Cell 125 2006 1269 1281 (Pubitemid 43949521)
30. K.S. Koeneman, C.X. Pan, J.K. Jin, J.M. Pyle 3rd, R.C. Flanigan, T.V. Shankey, and M.O. Diaz Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN) J. Urol. 160 1998 1533 1539 (Pubitemid 29480573)
31. J. Lapointe, C. Li, J.P. Higgins, M. van de Rijn, E. Bair, K. Montgomery, M. Ferrari, L. Egevad, W. Rayford, and U. Bergerheim Gene expression profiling identifies clinically relevant subtypes of prostate cancer Proc. Natl. Acad. Sci. USA 101 2004 811 816 (Pubitemid 38121040)
32. E. LaTulippe, J. Satagopan, A. Smith, H. Scher, P. Scardino, V. Reuter, and W.L. Gerald Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease Cancer Res. 62 2002 4499 4506 (Pubitemid 34827314)
33. H.W. Lee, M.A. Blasco, G.J. Gottlieb, J.W. Horner 2nd, C.W. Greider, and R.A. DePinho Essential role of mouse telomerase in highly proliferative organs Nature 392 1998 569 574 (Pubitemid 28207706)
34. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S.I. Wang, J. Puc, C. Miliaresis, L. Rodgers, and R. McCombie PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947 (Pubitemid 27148818)
35. Y. Lin, H. Uemura, K. Fujinami, M. Hosaka, M. Harada, and Y. Kubota Telomerase activity in primary prostate cancer J. Urol. 157 1997 1161 1165 (Pubitemid 27066336)
36. S. Marino, M. Vooijs, H. van Der Gulden, J. Jonkers, and A. Berns Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum Genes Dev. 14 2000 994 1004 (Pubitemid 30253007)
37. R.S. Maser, B. Choudhury, P.J. Campbell, B. Feng, K.K. Wong, A. Protopopov, J. O'Neil, A. Gutierrez, E. Ivanova, and I. Perna Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers Nature 447 2007 966 971 (Pubitemid 46975753)
38. A.K. Meeker, J.L. Hicks, E.A. Platz, G.E. March, C.J. Bennett, M.J. Delannoy, and A.M. De Marzo Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis Cancer Res. 62 2002 6405 6409 (Pubitemid 35364095)
39. R.C. O'Hagan, S. Chang, R.S. Maser, R. Mohan, S.E. Artandi, L. Chin, and R.A. DePinho Telomere dysfunction provokes regional amplification and deletion in cancer genomes Cancer Cell 2 2002 149 155 (Pubitemid 41039115)
40. M. Ongenaert, L. Van Neste, T. De Meyer, G. Menschaert, S. Bekaert, and W. Van Criekinge PubMeth: a cancer methylation database combining text-mining and expert annotation Nucleic Acids Res. 36 Database issue 2008 D842 D846
41. M.A. Rubin Targeted therapy of cancer: new roles for pathologists - prostate cancer Mod. Pathol. 21 Suppl 2 2008 S44 S55
42. K.L. Rudolph, M. Millard, M.W. Bosenberg, and R.A. DePinho Telomere dysfunction and evolution of intestinal carcinoma in mice and humans Nat. Genet. 28 2001 155 159 (Pubitemid 32538061)
43. J.W. Shay, and W.E. Wright Telomerase therapeutics for cancer: challenges and new directions Nat. Rev. Drug Discov. 5 2006 577 584 (Pubitemid 43971192)
44. H.J. Sommerfeld, A.K. Meeker, M.A. Piatyszek, G.S. Bova, J.W. Shay, and D.S. Coffey Telomerase activity: a prevalent marker of malignant human prostate tissue Cancer Res. 56 1996 218 222 (Pubitemid 26011466)
45. Z. Storchova, and D. Pellman From polyploidy to aneuploidy, genome instability and cancer Nat. Rev. Mol. Cell Biol. 5 2004 45 54 (Pubitemid 38089840)
46. M.R. Stratton, P.J. Campbell, and P.A. Futreal The cancer genome Nature 458 2009 719 724
47. H. Takai, A. Smogorzewska, and T. de Lange DNA damage foci at dysfunctional telomeres Curr. Biol. 13 2003 1549 1556 (Pubitemid 37078413)
48. B.S. Taylor, N. Schultz, H. Hieronymus, A. Gopalan, Y. Xiao, B.S. Carver, V.K. Arora, P. Kaushik, E. Cerami, and B. Reva Integrative genomic profiling of human prostate cancer Cancer Cell 18 2010 11 22
49. S.A. Tomlins, D.R. Rhodes, S. Perner, S.M. Dhanasekaran, R. Mehra, X.W. Sun, S. Varambally, X. Cao, J. Tchinda, and R. Kuefer Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 310 2005 644 648 (Pubitemid 41528150)
50. D.K. Vanaja, J.C. Cheville, S.J. Iturria, and C.Y. Young Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression Cancer Res. 63 2003 3877 3882 (Pubitemid 36917897)
51. S. Varambally, J. Yu, B. Laxman, D.R. Rhodes, R. Mehra, S.A. Tomlins, R.B. Shah, U. Chandran, F.A. Monzon, and M.J. Becich Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression Cancer Cell 8 2005 393 406 (Pubitemid 41579834)
52. B. Vukovic, P.C. Park, J. Al-Maghrabi, B. Beheshti, J. Sweet, A. Evans, J. Trachtenberg, and J. Squire Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma Oncogene 22 2003 1978 1987 (Pubitemid 36523635)
53. X. Wu, J. Wu, J. Huang, W.C. Powell, J. Zhang, R.J. Matusik, F.O. Sangiorgi, R.E. Maxson, H.M. Sucov, and P. Roy-Burman Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation Mech. Dev. 101 2001 61 69 (Pubitemid 32186310)
54. Y.P. Yu, D. Landsittel, L. Jing, J. Nelson, B. Ren, L. Liu, C. McDonald, R. Thomas, R. Dhir, and S. Finkelstein Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy J. Clin. Oncol. 22 2004 2790 2799 (Pubitemid 41079896)
55. L. Zender, M.S. Spector, W. Xue, P. Flemming, C. Cordon-Cardo, J. Silke, S.T. Fan, J.M. Luk, M. Wigler, and G.J. Hannon Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach Cell 125 2006 1253 1267 (Pubitemid 43929093)
56. W. Zhang, L.R. Kapusta, J.M. Slingerland, and L.H. Klotz Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium Cancer Res. 58 1998 619 621 (Pubitemid 28099467)
57. H. Zheng, H. Ying, H. Yan, A.C. Kimmelman, D.J. Hiller, A.J. Chen, S.R. Perry, G. Tonon, G.C. Chu, and Z. Ding p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation Nature 455 2008 1129 1133